Literature DB >> 6224756

Posterior and anterior permeability defects? Morphologic observations on streptozotocin-treated rats.

I H Wallow.   

Abstract

Structural abnormalities of the blood-ocular barrier were examined in streptozotocin (STZ)-treated hyperglycemic rats, after 9 days, 6 months, and 10 months' duration of "diabetes," and in normoglycemic control animals using the horseradish peroxidase tracer technique combined with light and electron microscopy. The most frequent abnormalities consisted of small areas of diffuse dense staining by the tracer of (1) the retinal pigment epithelium and (2) the nonpigmented ciliary epithelium. Pigment epithelium abnormalities occurred occasionally in both groups of animals with approximately equal frequency and extent. Ciliary body abnormalities occurred also in both groups, but were frequent; statistically, the probability of these changes was not significantly different between the two groups. At the ora serrata, tracer escape was present through the retinal pigment epithelium into subretinal space and retina. Retinal vascular leakage occurred rarely and may be related to tracer toxicity rather than hyperglycemia. Thus, using the HRP method, we cannot confirm the claim that sustained STZ-induced hyperglycemia causes breakdown of the blood-retinal barrier in the rat.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224756

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group.

Authors:  T W Gardner; D A Antonetti; A J Barber; E Lieth; J A Tarbell
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

2.  Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics.

Authors:  S A Vinores; C Gadegbeku; P A Campochiaro; W R Green
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

3.  Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy.

Authors:  T W Gardner
Journal:  Trans Am Ophthalmol Soc       Date:  1995

4.  Non-retinovascular leakage in diabetic maculopathy.

Authors:  D Weinberger; S Fink-Cohen; D D Gaton; E Priel; Y Yassur
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

5.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

6.  Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina.

Authors:  T Murata; T Ishibashi; H Inomata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  Immunohistochemical detection of blood-retinal barrier breakdown in streptozotocin-diabetic rats.

Authors:  T Murata; T Ishibashi; H Inomata
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-03       Impact factor: 3.117

8.  Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathy.

Authors:  Haiyan Jiang; Junxu Fang; Bo Wu; Guibin Yin; Lin Sun; Jia Qu; Steven W Barger; Shengzhou Wu
Journal:  J Neuroinflammation       Date:  2011-09-22       Impact factor: 8.322

9.  Proteomics identifies new potential therapeutic targets of diabetic retinopathy.

Authors:  Huanran Zhou; Qian Xu; Hongxue Li; Yuxin Hu; Hongyu Kuang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 10.  Photoreceptor cells and RPE contribute to the development of diabetic retinopathy.

Authors:  Deoye Tonade; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2020-11-12       Impact factor: 19.704

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.